Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLFCR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļLifecore Biomedical Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 15, 1996
āļāļĩāļāļĩāđāļJosephs (Paul)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ406
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 15
āļāļĩāđāļāļĒāļđāđ3515 Lyman Boulevard
āđāļĄāļ·āļāļCHASKA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ55318
āđāļāļĢāļĻāļąāļāļāđ19523684300
āđāļ§āđāļāđāļāļāđhttps://www.lifecore.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLFCR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 15, 1996
āļāļĩāļāļĩāđāļJosephs (Paul)
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Ryan David Lake
Chief Financial Officer
Mr. Joshua E. Schechter
Independent Director
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
Mr. Jason M. Aryeh
Independent Director
Mr. Nelson Obus
Independent Director
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Ms. Stephanie Diaz
Investor Relations
Mr. Paul H. Johnson
Independent Director
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Ryan David Lake
Chief Financial Officer
Mr. Joshua E. Schechter
Independent Director
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
Mr. Jason M. Aryeh
Independent Director
Mr. Nelson Obus
Independent Director
WisdomTree US SmallCap Fund
Global X Russell 2000 ETF
Invesco Russell 2000 Dynamic Multifactor ETF
Proshares Ultra Russell 2000
iShares Russell 2000 Growth ETF
ProShares UltraPro Russell2000
Motley Fool Next Index ETF
ProShares Hedge Replication ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
WisdomTree US SmallCap Fund
āļŠāļąāļāļŠāđāļ§āļ0.03%
Global X Russell 2000 ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
iShares Russell 2000 ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Proshares Ultra Russell 2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
iShares Russell 2000 Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
ProShares UltraPro Russell2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
Motley Fool Next Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
ProShares Hedge Replication ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ